Source: Program and Abstracts. Conference titles: The Endocrine Society's Annual Meeting. Unidade: FM
Subjects: CRIANÇAS, SEGUIMENTOS, HORMÔNIO DO CRESCIMENTO (TERAPIA), MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JORGE. ALEXANDRE A. L., et al. Patients with Noonan syndrome without mutation in PTPN11repond better to GH treatment than patients with PTPN11 mutations. 2005, Anais.. San Diego: Faculdade de Medicina, Universidade de São Paulo, 2005. . Acesso em: 01 dez. 2025.APA
Jorge. Alexandre A. L.,, Ferreira, L. V., Souza, S. A. L., Arnhold, I. J. P., & Mendonça, B. B. (2005). Patients with Noonan syndrome without mutation in PTPN11repond better to GH treatment than patients with PTPN11 mutations. In Program and Abstracts. San Diego: Faculdade de Medicina, Universidade de São Paulo.NLM
Jorge. Alexandre A. L., Ferreira LV, Souza SAL, Arnhold IJP, Mendonça BB. Patients with Noonan syndrome without mutation in PTPN11repond better to GH treatment than patients with PTPN11 mutations. Program and Abstracts. 2005 ;[citado 2025 dez. 01 ]Vancouver
Jorge. Alexandre A. L., Ferreira LV, Souza SAL, Arnhold IJP, Mendonça BB. Patients with Noonan syndrome without mutation in PTPN11repond better to GH treatment than patients with PTPN11 mutations. Program and Abstracts. 2005 ;[citado 2025 dez. 01 ]
